| Titolo |
Pubblicato in |
Anno |
| Residents and Consultants Have Equal Outcomes When Performing Transrectal Fusion Biopsies: A Randomized Clinical Trial |
CURRENT ONCOLOGY |
2024 |
| Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries |
UROLOGY |
2024 |
| Quality of information and appropriateness of Open AI outputs for prostate cancer |
PROSTATE CANCER AND PROSTATIC DISEASES |
2024 |
| Yoga, benign prostatic hyperplasia and lower urinary tract symptoms: a new path for clinical trials |
PROSTATE CANCER AND PROSTATIC DISEASES |
2024 |
| Sexual and reproductive health: level of knowledge and source of information in adolescence |
JOURNAL OF SEXUAL MEDICINE |
2024 |
| Open versus Minimally Invasive Partial Nephrectomy: Trends and Outcomes from a Wide National Population-Based Database |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique |
DIAGNOSTICS |
2024 |
| Purely Off-Clamp Sutureless Robotic Partial Nephrectomy for Novice Robotic Surgeons: A Multi-Institutional Propensity Score-Matched Analysis |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Trends and incidence of reported events associated with ureteral stents: an analysis of the food and drug administration's manufacturer and user facility device experience (MAUDE) database |
WORLD JOURNAL OF UROLOGY |
2024 |
| Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate |
LIFE |
2024 |
| Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH |
PROSTATE CANCER AND PROSTATIC DISEASES |
2024 |
| Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database |
MINERVA UROLOGY AND NEPHROLOGY |
2024 |
| Evaluation of peri-operative outcomes after prostatic urethral lift with emphasis on urodynamic changes, symptom improvement and sexual function |
DIAGNOSTICS |
2024 |
| No clinical benefit from sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) than BCG alone in the adjuvant treatment of high risk non muscle invasive bladder cancer: result of a planned interim analysis of a prospective randomized trial |
MINERVA UROLOGY AND NEPHROLOGY |
2024 |
| Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2 |
CANCERS |
2023 |
| Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram |
METABOLITES |
2023 |
| Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries |
PROSTATE CANCER AND PROSTATIC DISEASES |
2023 |
| Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram |
CLINICAL GENITOURINARY CANCER |
2023 |
| Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries |
MINERVA UROLOGY AND NEPHROLOGY |
2023 |
